Doctor's Bio
Board Certifications
American Board of Urology
Affiliations
Emory
Education & Training
- Medical School: Harlem Hospital Center
- Residency: Johns Hopkins Hospital
Fellowships
National Cancer Institute, NIH
Locations and Directions
Grady Memorial Hospital
Phone: (404) 616-1000
Location:
80 Jesse Hill Jr Drive SE
Atlanta, GA 30303
Publications
- Patient-reported psychological and prostate cancer-specific functional outcomes among men with low-risk prostate cancer two years after diagnosis: The PREPARE prospective cohort study.
Davis KM, Luta G, Hoffman RM, Lobo T, Zotou V, Potosky AL, Sanda MG, Penson D, Khosrow-Khavar F, Ergas IJ, Van Den Eeden SK, Taylor KL
Urology. 2026;
PMID: 41819414 - Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2:ERG RNA Testing Improves Detection of Clinically Significant Prostate Cancer.
Eyrich NW, Huang Y, Zheng Y, Wei J, Sokoll L, Chan DW, Patil D, Chinnaiyan A, Tomlins SA, Lotan Y, Lin D, Scherr D, Wang Y, Kibel A, Taneja SS, Bidair M, Thompson IM, Sanda MG, Narayan VM
JU open plus. 2026;4(2):e00019.
PMID: 41709952 - Coronary Plaque Progression After Androgen Deprivation Therapy in Men With Prostate Cancer: A Randomized Clinical Trial.
Patel SA, Yadalam AK, van Assen M, Cantu SM, Onnis C, Zheng B, Koo A, Goyal S, Liu Y, Liu C, Sebastian NT, Dhere VR, Hershatter BW, Patel PR, Chaudagar K, Stillman AE, De Cecco CN, Sanda MG, Jani AB, Mandawat A
JAMA cardiology. 2026;
PMID: 41706486 - Cross-cultural adaptation and psychometric validation of the Finnish version of the Expanded Prostate Cancer Index Composite-26 for patients with localised prostate cancer.
Ettala O, Bergroth R, Riikonen J, Boström P, Koskimäki J, Kuisma J, Rannikko A, Vaarala M, Sanda MG, Santti H
Scandinavian journal of urology. 2025;
PMID: 40859718 - Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United States.
Janopaul-Naylor JR, Patil D, Joshi S, Sanda MG, Sebastian N, Salari K, Dodge J, Dhere VR, Hershatter BW, Patel PR, Jani AB, Filson C, Patel SA
JCO precision oncology. 2025;
PMID: 40834325 - NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling.
Lu X, Keo V, Cheng I, Xie W, Gritsina G, Wang J, Lu L, Shiau CK, He Y, Jin Q, Jin P, Sanda MG, Corces VG, Altemose N, Gao R, Zhao JC, Yu J
Nature genetics. 2025;57(8):1966-1980.
PMID: 40691407 - A simplified MyProstateScore2.0 for high-grade prostate cancer.
Tang TM, Zhang Y, Kenney AM, Xie C, Xiao L, Siddiqui J, Srivastava S, Sanda MG, Wei JT, Feng Z, Tosoian JJ, Zheng Y, Chinnaiyan AM, Yu B,
Cancer biomarkers : section A of Disease markers. 2025;42(1):18758592241308755.
PMID: 40109218 - Utilization, health care expenditures, and patient costs of definitive treatment modalities for localized prostate cancer in the United States.
Sebastian NT, Patil D, Patel PR, Jani AB, Hershatter BW, Dhere VR, Godette KD, Lorentz CA, Weiss AD, Joshi SS, Sanda MG, Patel SA
Cancer. 2025;131(6):e35795.
PMID: 40038572 - Epigenetic remodeling and 3D chromatin reorganization governed by NKX2-1 drive neuroendocrine prostate cancer.
Lu X, Keo V, Cheng I, Xie W, Gritsina G, Wang J, Jin Q, Jin P, Yue F, Sanda MG, Corces V, Altemose N, Zhao JC, Yu J
bioRxiv : the preprint server for biology. 2024;
PMID: 39677680 - The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature.
Palmateer G, Nicaise EH, Gandhi J, Goodstein T, Sheng M, Ogan K, Kucuk O, Yushak M, Sanda MG, Delman KA, Master V
Urology case reports. 2024;
PMID: 39553440
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.